Published in BMC Med on March 14, 2013
Increasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysis. BMJ Open (2015) 2.13
Global health: the importance of evidence-based medicine. BMC Med (2013) 1.02
A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80
Bibliometric analysis of scientific publications in transplantation journals from Mainland China, Japan, South Korea and Taiwan between 2006 and 2015. BMJ Open (2016) 0.77
BMC Medicine: a decade of open access medical research. BMC Med (2014) 0.75
Current status on health sciences research productivity pertaining to Angola up to 2014. Health Res Policy Syst (2015) 0.75
Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
A bibliometric analysis of global research production in respiratory medicine. Chest (2005) 4.15
Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet (2008) 3.28
Trends in health policy and systems research over the past decade: still too little capacity in low-income countries. PLoS One (2011) 2.99
A call to action for the new decade of vaccines. Lancet (2011) 2.72
Geography of Africa biomedical publications: an analysis of 1996-2005 PubMed papers. Int J Health Geogr (2007) 2.16
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09
A new global immunisation vision and strategy. Lancet (2006) 1.74
Bibliometric analysis of global trends for research productivity in microbiology. Eur J Clin Microbiol Infect Dis (2005) 1.65
Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals. Vaccine (2008) 1.65
International gastroenterology research: subject areas, impact, and funding. Gut (2001) 1.60
Biomedical research productivity: factors across the countries. Int J Technol Assess Health Care (2003) 1.58
Accuracy and quality of immunization information systems in forty-one low income countries. Trop Med Int Health (2009) 1.56
Call for more research on injury from the developing world: results of a bibliometric analysis. Indian J Med Res (2009) 1.48
Reporting of non-communicable disease research in low- and middle-income countries: a pilot bibliometric analysis. J Med Libr Assoc (2006) 1.42
A bibliometric analysis of research productivity in Parasitology by different world regions during a 9-year period (1995-2003). BMC Infect Dis (2006) 1.40
What is the future of primary care research? Probably fairly bright, if we may believe the historical development. Scand J Prim Health Care (2005) 1.39
The future of immunisation policy, implementation, and financing. Lancet (2011) 1.36
The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine (2011) 1.26
A bibliometric analysis of global trends of research productivity in tropical medicine. Acta Trop (2006) 1.24
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
Reaching every district (RED) approach to strengthen routine immunization services: evaluation in the African region, 2005. J Public Health (Oxf) (2009) 1.18
Strengthening research capacity. Lancet (2002) 1.18
'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research. Implement Sci (2011) 1.12
Make the money work for health in sub-Saharan Africa. Lancet (2009) 1.09
Accelerated measles control in sub-Saharan Africa. Lancet (2006) 1.09
Effects of assessing the productivity of faculty in academic medical centres: a systematic review. CMAJ (2012) 1.06
On geography and medical journalology: a study of the geographical distribution of articles published in a leading medical informatics journal between 1999 and 2004. Int J Health Geogr (2005) 1.04
Ethics of human genetic studies in sub-saharan Africa: the case of Cameroon through a bibliometric analysis. Dev World Bioeth (2011) 1.01
HIV/AIDS in Nigeria: a bibliometric analysis. BMC Infect Dis (2008) 0.96
[Bibliometric analysis of the current international ophthalmic publications]. Nippon Ganka Gakkai Zasshi (2005) 0.92
A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS). BMC Public Health (2011) 0.91
Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers. BMC Infect Dis (2010) 0.88
Factors related to biomedical research productivity in Asian countries. J Epidemiol (2001) 0.87
Researching routine immunization-do we know what we don't know? Vaccine (2011) 0.77
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol (2008) 3.19
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 2.50
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol (2010) 2.25
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis (2011) 2.24
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med (2010) 2.03
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev (2010) 1.94
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev (2012) 1.77
Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72
Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis (2008) 1.66
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis (2006) 1.64
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis (2013) 1.57
Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J Clin Microbiol (2010) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol (2006) 1.40
European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership. BMC Public Health (2009) 1.35
Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med (2013) 1.32
A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa. BMC Infect Dis (2002) 1.32
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31
Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
Early warning indicators for HIV drug resistance in Cameroon during the year 2010. PLoS One (2012) 1.16
Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med (2009) 1.14
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis (2009) 1.12
Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS (2012) 1.12
Risk factors and a predictive model for under-five mortality in Nigeria: evidence from Nigeria demographic and health survey. BMC Pregnancy Childbirth (2012) 1.12
'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research. Implement Sci (2011) 1.12
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09
Individual and contextual factors associated with childhood stunting in Nigeria: a multilevel analysis. Matern Child Nutr (2011) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. Vaccine (2010) 1.03
Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr (2002) 1.01
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One (2012) 0.99
Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings. BMC Public Health (2013) 0.94
Impact of malaria on hematological parameters in people living with HIV/AIDS attending the Laquintinie Hospital in Douala, Cameroon. PLoS One (2012) 0.90
Making BCG vaccination programmes safer in the HIV era. Lancet (2008) 0.90
Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.89
Factors that affect the uptake of community-based health insurance in low-income and middle-income countries: a systematic protocol. BMJ Open (2014) 0.89
Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89
Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol. Syst Rev (2013) 0.89
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev (2013) 0.89
Some social determinants of urinary schistosomiasis in Northern Cameroon: implications for schistosomiasis control. Afr J Health Sci (2007) 0.88
Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health (2007) 0.88
Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers. BMC Infect Dis (2010) 0.88
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection. Pediatr Infect Dis J (2016) 0.88
Exploring variations in childhood stunting in Nigeria using league table, control chart and spatial analysis. BMC Public Health (2013) 0.88
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol (2008) 0.87
An update of malaria infection and anaemia in adults in Buea, Cameroon. BMC Res Notes (2010) 0.87
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis (2012) 0.87
Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid. Open AIDS J (2009) 0.86
Hematuria and dysuria in the self-diagnosis of urinary schistosomiasis among school-children in Northern Cameroon. Afr J Health Sci (2007) 0.85
The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol. BMJ Open (2014) 0.85
Yellow fever control in Cameroon: where are we now and where are we going? BMC Med (2008) 0.84
Developing vaccinology expertise for Africa: six years and counting. Vaccine (2011) 0.84
Sexual behavior of HIV-positive women in Cameroon. J Int Assoc Provid AIDS Care (2011) 0.84
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J (2011) 0.83
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.83
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women. Cochrane Database Syst Rev (2011) 0.83
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J (2002) 0.83
High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiol (2011) 0.82
Lessons and myths in the HIV/AIDS response. Lancet (2009) 0.81
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80
Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call. J AIDS Clin Res (2013) 0.79
Social disorganization and history of child sexual abuse against girls in sub-Saharan Africa: a multilevel analysis. BMC Int Health Hum Rights (2013) 0.79
Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol (2013) 0.79
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (2016) 0.78
Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC Res Notes (2012) 0.78
Use of systematic reviews in WHO recommendations. Lancet (2011) 0.77
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load. AIDS Res Hum Retroviruses (2011) 0.77
Bacteriuria amongst pregnant women in the Buea Health District, Cameroon: prevalence, predictors, antibiotic susceptibility patterns and diagnosis. PLoS One (2013) 0.77
Impact of antiretroviral therapy on glycemia and transaminase levels in patients living with HIV/AIDS in Limbe, Cameroon. J Int Assoc Provid AIDS Care (2012) 0.77
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev (2013) 0.76
Individual and community-level socioeconomic position and its association with adolescents experience of childhood sexual abuse: a multilevel analysis of six countries in Sub-Saharan Africa. J Inj Violence Res (2013) 0.75
Meta-analysis of randomized controlled trials on the treatment of pulmonary arterial hypertension. Circ J (2010) 0.75
The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. Pediatr Infect Dis J (2015) 0.75
Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev (2014) 0.75
Public stewardship of private for-profit healthcare providers in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol. Syst Rev (2014) 0.75
Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon. BMC Res Notes (2012) 0.75
Universal access to antiretroviral therapy: are we moving the targets? J Int Assoc Physicians AIDS Care (Chic) (2009) 0.75
Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis. S Afr Med J (2012) 0.75
The Burden of Hypertension in an Oil- and Gas-Polluted Environment: A Comparative Cross-Sectional Study. Am J Hypertens (2016) 0.75